A Phase Iii Trial (Zjbi0009): Cmaboo9 Plus Irinotecan Versus Irinotecan Alone As Second-Line Treatment After Fluoropyrimidine And Oxaliplatin Failure In Wild-Type K-Ras Metastatic Colorectal Cancer Patients.
JOURNAL OF CLINICAL ONCOLOGY(2017)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要